Combine Effects of Brunnstorm Movement Therapy and LLLT in Chronic Stroke Patient

Combine Effects of Brunnstorm Movement Therapy and LLLT on Upper Limb Functioning and Hand Dexterity in Chronic Stroke Patient

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT06292481

Enrollment

Registered

2024-03-05

Start date

2023-08-01

Completion date

2023-10-10

Last updated

2024-03-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Stroke

Keywords

Brunnstorm movement therapy, Hand dexterity, Low-level laser therapy, Stroke

Brief summary

The primary objective of this study is to determine the combined effects of Brunnstorm movement therapy and low level laser therapy on upper limb function in chronic stroke patient.

Interventions

OTHERBrunnstorm movement therapy

this group received Brunnstorm Movement therapy for 3 to 5 sessions per week, each lasting approximately 30 to 60 minutes for 6 weeks

OTHERCombined Brunnstorm Movement therapy and low level laser therapy

this group received Combined Brunnstorm Movement therapy and low level laser therapy for 3 to 5 sessions per week, each lasting approximately 30 to 60 minutes for 6 weeks

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender

ALL

Age

40 Years to 60 Years

Healthy volunteers

Yes

Inclusion criteria

* Age range between 40 & 60 years (16) * Both males and females. * Combined Effects of Brunnstorm movement therapy and LLLT on Upper limb function Hand dexterity in stroke * Patient with maximum Grade 1 and 1+ spasticity according to Modified * Ashworth scale and minimum muscle strength of 1 in the biceps brachii muscle. * Onset of injury : (1 to 2 years)

Exclusion criteria

* Any comorbidity such as malignancy, inflammatory rheumatologic disease, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, lupus erythematosus, etc. * Have a pacemaker or a history of serious cardiac events or of cardiorespiratory dysfunction. * Visual impairment * Any other musculoskeletal disorders of extremity * Severe cognitive impairment or aphasia leading to difficulty in communication, Participants unwilling to comply with the protocol.

Design outcomes

Primary

Measure	Time frame	Description
Fugle meyer Assessment test	6th week	—
Box and block test	6th week	—
Nine peg hole test	6th week	—
to check Muscle tone	6th week	Modified Ashworth Scale
to measure grip Strength	6th week	Hand handled dynamometer

Countries

Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026